Valuation Update With 7 Day Price Move • Apr 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to US$1.50, the stock trades at a trailing P/E ratio of 28.4x. Average trailing P/E is 20x in the IT industry in the US. Valuation Update With 7 Day Price Move • Mar 30
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to US$1.55, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 19x in the IT industry in the US. New Risk • Mar 19
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$9.60m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). High level of non-cash earnings (47% accrual ratio). Market cap is less than US$10m (US$9.60m market cap). Minor Risks Latest financial reports are more than 6 months old (reported January 2025 fiscal period end). Revenue is less than US$5m (US$2.7m revenue). Valuation Update With 7 Day Price Move • Jan 21
Investor sentiment improves as stock rises 37% After last week's 37% share price gain to US$2.35, the stock trades at a trailing P/E ratio of 44.5x. Average trailing P/E is 27x in the IT industry in the US. New Risk • Jan 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended January 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). High level of non-cash earnings (47% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported January 2025 fiscal period end). Revenue is less than US$5m (US$2.7m revenue). Market cap is less than US$100m (US$12.6m market cap). Valuation Update With 7 Day Price Move • Dec 26
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to US$1.77, the stock trades at a trailing P/E ratio of 33.5x. Average trailing P/E is 30x in the IT industry in the US. Valuation Update With 7 Day Price Move • Dec 11
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to US$4.12, the stock trades at a trailing P/E ratio of 78x. Average trailing P/E is 31x in the IT industry in the US. New Risk • Nov 20
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 47% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (26% average weekly change). High level of non-cash earnings (47% accrual ratio). Minor Risks Revenue is less than US$5m (US$2.7m revenue). Market cap is less than US$100m (US$23.1m market cap). Board Change • Nov 18
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Gabriel Loh is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. 공지 • Nov 13
Black Titan Corporation Appoints Czhang Lin as Co Chief Executive Officer Black Titan Corporation announced the appointment of Czhang Lin as Co-Chief Executive Officer, further strengthening the Company's leadership team as it accelerates its strategic expansion into the digital asset and blockchain sectors. Mr. Lin brings deep expertise in the cryptocurrency and blockchain ecosystem, with a track record of investing in and advising high-growth Web3 projects around the world since 2017. He has collected a vast network over the last 8 years by investing in projects or taking key roles in various funds, that include Binance labs and now currently serves as investment committee for Lbank Labs. Mr. Lin has been instrumental in identifying early-stage opportunities and driving institutional adoption of blockchain technologies. In his new role as Co-CEO, Mr. Lin will lead Black Titans crypto strategy, focusing on strategic investments in digital currencies, direct token acquisitions, blockchain infrastructure, mining operations, and fintech-related mergers and acquisitions. He will work closely with the executive team to position Black Titan at the forefront of the evolving digital asset landscape and unlock long-term value for shareholders. His appointment marks the next step in broader strategy to build a diversified digital asset portfolio and capture opportunities in a rapidly maturing market. 공지 • Oct 03
Ke Sdn. Bhd. completed the acquisition of Titan Pharmaceuticals, Inc. (NasdaqCM:TTNP) in a reverse merger transaction. Ke Sdn. Bhd. entered into an agreement to acquire Titan Pharmaceuticals, Inc. (NasdaqCM:TTNP) for $21.6 million in a reverse merger transaction on August 19, 2024. Upon completion of the merger, the existing security holders of Ke Sdn. Bhd. ("KE") and Titan (excluding The Sire Group Ltd. and current Titan directors and officers) expect to own approximately 86.7% and 13.3%, respectively, of the outstanding shares of the combined company. It is expected that Dato’ Seow Gim Shen will own 48.9% of the outstanding shares of the combined company following the merger. Completion of the merger is subject to the approval of the merger by Titan’s stockholders, the registration statement shall have become effective, shares to be issued in connection with the transaction shall have been approved for listing on Nasdaq and satisfaction or waiver of other customary conditions. The agreement was unanimously approved by Titan’s board of directors. KE board of directors also approved the transaction. As of June 3, 2025, the transaction is expected to close in the third quarter of 2025. As of August 26, 2025, Titan Pharmaceuticals approved the transaction.
Kenneth Schlesinger and Claudia Dubon of Olshan Frome Wolosky LLP acted as legal advisor to Titan Pharmaceuticals, Inc. Mitchell S. Nussbaum of Loeb & Loeb LLP acted as legal advisor to KE Sdn Bhd.
Ke Sdn. Bhd. completed the acquisition of Titan Pharmaceuticals, Inc. (NasdaqCM:TTNP) in a reverse merger transaction on October 1, 2025. As a result of the Merger, it is anticipated that shares of TTNP common stock will cease trading on the Nasdaq Capital Market (“ Nasdaq ”) and PubCo Ordinary Shares will begin trading on Nasdaq commencing with the opening of trading on Thursday, October 2, 2025. TTNP’s directors and officers offered their resignations for serving in such capacities, at the request of Black Titan and not because of any disagreement with TTNP regarding any matter related to TTNP’s operations, policies or practices, and Chay Weei Jye was appointed as the sole director and acting secretary of TTNP. 
